Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Identification of a prognostic gene signature in patients with cisplatin resistant squamous cell lung cancer.

Autor: Mu Y; Radiation Oncology Department of Breast Cancer, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China., Dong Y; Department of Thoracic Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China., Zheng M; Department of Gynaecology and Obstetrics, Fushun Central Hospital, Fushun, China., Barr MP; Thoracic Oncology Research Group, School of Medicine, Trinity Translational Medicine Institute, Trinity Centre for Health Sciences, Trinity College Dublin & Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland., Roviello G; Department of Health Sciences, University of Florence, Florence, Italy., Hu Z; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Liu J; Department of Gynecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.

Publikováno v: Journal of thoracic disease [J Thorac Dis] 2024 Jul 30; Vol. 16 (7), pp. 4567-4583. Date of Electronic Publication: 2024 Jul 26.

Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma.

Autor: Song W; Department of Pharmacy, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.; Henan Engineering Research Center for Tumor Precision Medicine and Comprehensive Evaluation, Henan Cancer Hospital, Zhengzhou, China.; Henan Provincial Key Laboratory of Anticancer Drug Research, Henan Cancer Hospital, Zhengzhou, China., Wu X; Department of Internal Medicine, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China., Wang S; Department of Respiratory and Critical Care Medicine, Henan Provincial Chest Hospital, Zhengzhou, China., Barr MP; Thoracic Oncology Research Group, School of Medicine, Trinity Translational Medicine Institute, Trinity Centre for Health Sciences, St. James's Hospital and Trinity College Dublin, Dublin, Ireland., Rodríguez M; Department of Thoracic Surgery, Clínica Universidad de Navarra, Madrid, Spain., Oh IJ; Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Jeonnam, Republic of Korea., Wu Y; Department of Internal Medicine, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China., Li D; Department of Pharmacy, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.; Henan Engineering Research Center for Tumor Precision Medicine and Comprehensive Evaluation, Henan Cancer Hospital, Zhengzhou, China.; Henan Provincial Key Laboratory of Anticancer Drug Research, Henan Cancer Hospital, Zhengzhou, China.

Publikováno v: Translational lung cancer research [Transl Lung Cancer Res] 2023 Dec 26; Vol. 12 (12), pp. 2476-2493. Date of Electronic Publication: 2023 Dec 06.

Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses.

Autor: Mylod E; Cancer Immunology and Immunotherapy Group, Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland., McKenna E; Cancer Immunology and Immunotherapy Group, Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland., Davern M; Cancer Immunology and Immunotherapy Group, Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland., Barr MP; Thoracic Oncology Research Group, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland., Donlon NE; Cancer Immunology and Immunotherapy Group, Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland., Bibby BAS; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, M20 4BX, UK., Bhardwaj A; Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland., Reynolds JV; Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland.; National Oesophageal and Gastric Centre, St. James's Hospital, Dublin, Ireland., Lysaght J; Cancer Immunology and Immunotherapy Group, Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland., Maher SG; Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland., Conroy MJ; Cancer Immunology and Immunotherapy Group, Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland. meconroy@tcd.ie.; Department of Surgery, Trinity Translational Medicine Institute and Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, Dublin 8, Ireland. meconroy@tcd.ie.

Publikováno v: Clinical and experimental medicine [Clin Exp Med] 2023 Jun; Vol. 23 (2), pp. 411-425. Date of Electronic Publication: 2022 Apr 01.